Abstract

IntroductionHypothermia attenuates cerebral ischemia-induced neuronal cell death associated with neuroinflammation. The calcineurin inhibitor cyclosporin A (CsA) has been shown to be neuroprotective by minimizing activation of inflammatory pathways. Therefore, we investigated whether the combination of hypothermia and treatment with CsA has neuroprotective effects in an oxygen-glucose deprivation/reperfusion (OGD/R) injury model in neuronal and BV-2 microglia monocultures, as well as in an organotypic hippocampal slice culture (OHSC).MethodsMurine primary neurons, BV-2 microglia, and OHSC were pretreated with CsA and exposed to 1 h OGD (0.2% O2) followed by reperfusion at normothermia (37°C) or hypothermia (33.5°C). Cytotoxicity was measured by lactate dehydrogenase and glutamate releases. Damage-associated molecular patterns (DAMPs) high mobility group box 1 (HMGB1), heat shock protein 70 (Hsp70), and cold-inducible RNA-binding protein (CIRBP) were detected in cultured supernatant by western blot analysis. Interleukin-6 (IL-6), Interleukin-1α and -1β (IL-1α/IL1-β), tumor necrosis factor-α (TNF-α), monocyte chemotactic protein 1 (MCP1), inducible nitric oxide synthase (iNOS), glia activation factors ionized calcium-binding adapter molecule 1 (Iba1), and transforming growth factor β1 (TGF-β1) gene expressions were analyzed by RT-qPCR.ResultsExposure to OGD plus 10 μM CsA was sufficient to induce necrotic cell death and subsequent release of DAMPs in neurons but not BV-2 microglia. Moreover, OGD/R-induced secondary injury was also observed only in the neurons, which was not attenuated by cooling and no increased toxicity by CsA was observed. BV-2 microglia were not sensitive to OGD/R-induced injury but were susceptible to CsA-induced toxicity in a dose dependent manner, which was minimized by hypothermia. CsA attenuated IL-1β and Iba1 expressions in BV-2 microglia exposed to OGD/R. Hypothermia reduced IL-1β and iNOS expressions but induced TNF-α and Iba1 expressions in the microglia. However, these observations did not translate to the ex vivo OHCS model, as general high expressions of most cytokines investigated were observed.ConclusionTreatment with CsA has neurotoxic effects on primary neurons exposed to OGD but could inhibit BV-2 microglia activation. However, CsA and hypothermia treatment after ischemia/reperfusion injury results in cytotoxic neuroinflammation in the complex ex vivo OHSC.

Highlights

  • Hypothermia attenuates cerebral ischemia-induced neuronal cell death associated with neuroinflammation

  • We observed that initial exposure to OGD for 1 h did not significantly induce necrotic cell death compared to normoxic control in the primary neuronal and BV-2 microglial cell cultures, as measured by Lactate Dehydrogenase (LDH) release (Figures 2A,B)

  • We did not observe significant increased induction of the inflammatory pathways investigated in the oxygen-glucose deprivation/reperfusion (OGD/R)-induced injured slices, but surprisingly increases in tumor necrosis factor-α (TNF-α), IL-1α, IL-6, and monocyte chemotactic protein 1 (MCP1) expressions were observed when 10 μM cyclosporin A (CsA) was introduced, which was not observed in the Normoxia/R control treated with CsA nor in the BV-2 microglia under OGD/R+CsA conditions

Read more

Summary

Introduction

Hypothermia attenuates cerebral ischemia-induced neuronal cell death associated with neuroinflammation. Experimental investigations on the cytoprotective effects of hypothermia implicate a complex multi-modal response to protect from various ischemia/reperfusion injury mechanisms, Abbreviations: AP1, activator protein 1; CIRBP, cold-inducible RNA-binding protein; CNS, central nervous system; CsA, cyclosporin A; DAMP, damageassociated molecular pattern; DIV, days in vitro; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HMGB1, high mobility group box 1; Hsp, heat shock protein 70; iNOS, inducible nitric oxide synthase; Iba, ionized calciumbinding adapter molecule 1; IL-6, interleukin-6; IL-1α, interleukin-1α; IL-1β, interleukin-1β; LDH, lactate dehydrogenase; MAPK, mitogen-activated protein kinase; MCP1, monocyte chemotactic protein 1; NFAT, nuclear factor of activated T-cells; OGD, oxygen-glucose-deprivation; OGD/R, OGD and reperfusion; OHSC, organotypic hippocampal slice culture; PI, propidium iodide; PLL, poly-Llysin; RAGE, receptor for advanced glycation endproducts; RT-qPCR, reverse transcription quantitative polymerase chain reaction; TGF-β1, transforming growth factor-β1; TH, therapeutic hypothermia; TLR, toll-like receptor; TNF-α, tumor necrosis factor-α; TTM, targeted temperature management

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call